These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In Models of Intracerebral Hemorrhage, Rivaroxaban is Superior to Warfarin to Limit Blood Brain Barrier Disruption and Hematoma Expansion. Sawada S; Ono Y; Egashira Y; Takagi T; Tsuruma K; Shimazawa M; Iwama T; Hara H Curr Neurovasc Res; 2017; 14(2):96-103. PubMed ID: 27993122 [TBL] [Abstract][Full Text] [Related]
3. Pain in experimental autoimmune encephalitis: a comparative study between different mouse models. Lu J; Kurejova M; Wirotanseng LN; Linker RA; Kuner R; Tappe-Theodor A J Neuroinflammation; 2012 Oct; 9():233. PubMed ID: 23039175 [TBL] [Abstract][Full Text] [Related]
4. Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis. Klaren RE; Stasula U; Steelman AJ; Hernandez J; Pence BD; Woods JA; Motl RW J Neurosci Res; 2016 Oct; 94(10):907-14. PubMed ID: 27312674 [TBL] [Abstract][Full Text] [Related]
5. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis. Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322 [TBL] [Abstract][Full Text] [Related]
6. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis. Xie C; Ciric B; Yu S; Zhang GX; Rostami A J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis. Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885 [TBL] [Abstract][Full Text] [Related]
14. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse. Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735 [TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383 [TBL] [Abstract][Full Text] [Related]
16. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis. Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924 [TBL] [Abstract][Full Text] [Related]
17. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788 [TBL] [Abstract][Full Text] [Related]